期刊文献+

基于移动终端的糖尿病风险评估应用 被引量:2

下载PDF
导出
摘要 疾病风险评估是健康评估中的重要内容之一,是有关患病可能程度的评估,是健康管理中极为的重要环节。其依托个人健康水平、饮食营养、生活习惯、运动、心理、环境等诸多方面,共同构成个人健康管理体系。其作用是帮助评估对象发现某些病的患病可能性和程度,从而针对患病概率比较大的项目,采取积极、有效的预防措施,改善现有生活中的不良饮食习惯和生活习惯,或到相关医疗机构做进一步的临床检查和预防性治疗,以便最大限度地预防或延缓患病的发生。’
作者 魏庆锋
出处 《现代医药卫生》 2014年第16期2552-2553,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献6

二级参考文献19

  • 1鲍淑娣,张元亭.远程医疗:穿戴式生物医疗仪器[J].中国医疗器械信息,2004(5):1-3. 被引量:42
  • 2吴海云 潘平 何耀.我国成年人糖尿病发病风险评估方法.中华健康管理学杂志,2007,(1):95-98.
  • 3王陇德.中国居民营养与健康状况调查报告-2002综合报告.北京:人民卫生出版社,2005:1-59.
  • 4Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with life intervention or merformin. N Engl J Med, 2002, 346:393-403.
  • 5李明,关志强.健康风险评估和风险管理.//陈君石,黄建始.健康管理师.北京:中国协和医科大学出版社,2007:33-50.
  • 6Sehulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometrie, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care, 2007, 30: 510-515.
  • 7Al-Lawati JA, Tuomilehto J. Diabetes risk score in Oman: A tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Praet, 2007, 77:438-444.
  • 8Baan CA, Ruige JB, Stolk PP, et al. Performance of a predictive model to identify undignosed diabetes in a health care setting. Diabetes Care, 1999, 22: 213-219.
  • 9Lindstorrn J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes care, 2003, 26:725- 731.
  • 10Tabaei BP, Herman WH. A multivariate logistic regression equation to screen for diabetes. Diabetes Care, 2002, 25: 1999-2003.

共引文献104

同被引文献63

  • 1姜虹.医药物资协会发布行业发展蓝皮书[N].中华工商时报.2015-01-29(007).
  • 2李琦国.2014年移动医疗市场分析报告[EB/OL].[2014-11-29].http://www.SOOt00.com/content/534034.shtml.
  • 3Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386 (9995):743-800.
  • 4Mayes R, Armistead B. Chronic disease, prevention policy, and the future of public health and primary care Medicine, Health Care Philos. 2013; 16(4):691-697.
  • 5Hoyert DL, Xu JQ. Deaths: preliminary data for 2011. Natl Vital Stat Rep. 2012;61(6):1-51.
  • 6Brooke M J, Thompson BM. Food and Drug Administration regulation of diabetes-related mHealth technologies. J Diabetes Sci Technol. 2013;7(2):296-301.
  • 7Joshi R, Jan S, Wu Y, et al. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coil Cardiol.2008; 52(23): 1817-1825.
  • 8Murray C J, Lopez AD. Measuring the global burden of disease. New Eng J Med. 2013;369(5):448-457.
  • 9Hu X, Huang J, Lv Y, et al. Status of prevalence study on multimorbidity of chronic disease in China: systematic review. Geriatr Gerontol Int. 2015; 15(1 ): 1-10.
  • 10Muka T, Imo D, Jaspers L, et al. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251-277.

引证文献2

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部